Expression of regulatory receptors on γδ T Cells and their cytokine production in Behcet's disease

Arthritis Research and Therapy

Volumn 15, Issue 1, 2013, Pages

  Parlakgul, Gunes ^a   Guney, Ekin ^a   Erer, Burak ^a   Kilicaslan, Zeki ^a   Direskeneli, Haner ^b   Gul, Ahmet ^a   Saruhan Direskeneli, Guher ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2D; RANTES; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; BEHCET DISEASE; CELL EXPANSION; CELL FUNCTION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUBERCULOSIS; BIOSYNTHESIS; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; BEHCET SYNDROME; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84872417942     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4147     Document Type: Article

References (46)

1. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001, 60:996-1002. 10.1136/ard.60.11.996, 1753405, 11602462.
2. Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, Isogai E. Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci 2003, 60:1903-1922. 10.1007/s00018-003-2333-3, 14523551.
3. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010, 42:698-702. 10.1038/ng.625, 2923807, 20622878.
4. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, Bonneville M, Fournie JJ. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994, 264:267-270. 10.1126/science.8146660, 8146660.
5. Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J. Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human γδ T lymphocytes without inducing down-modulation of T cell antigen receptor. J Biol Chem 2001, 276:15961-15967. 10.1074/jbc.M008684200, 11278429.
6. Eberl M, Engel R, Beck E, Jomaa H. Differentiation of human γδ T cells towards distinct memory phenotypes. Cell Immunol 2002, 218:1-6. 10.1016/S0008-8749(02)00519-1, 12470608.
7. Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, Bernardi G, Poccia F, Fournie JJ, Battistini L. FcgammaRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways. Blood 2004, 104:1801-1807. 10.1182/blood-2004-01-0331, 15178578.
8. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996, 157:4741-4745.
9. Halary F, Peyrat MA, Champagne E, Lopez-Botet M, Moretta A, Moretta L, Vie H, Fournie JJ, Bonneville M. Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors. Eur J Immunol 1997, 27:2812-2821. 10.1002/eji.1830271111, 9394804.
10. Wesch D, Peters C, Oberg HH, Pietschmann K, Kabelitz D. Modulation of γδ T cell responses by TLR ligands. Cell Mol Life Sci 2011, 68:2357-2370. 10.1007/s00018-011-0699-1, 21560072.
11. Hedges JF, Lubick KJ, Jutila MA. γδ T cells respond directly to pathogen-associated molecular patterns. J Immunol 2005, 174:6045-6053.
12. Wesch D, Beetz S, Oberg H-H, Marget M, Krengel K, Kabelitz D. Direct costimulatory effect of TLR3 Ligand poly(I:C) on human γδ T lymphocytes. J Immunol 2006, 176:1348-1354.
13. Fortune F, Walker J, Lehner T. The expression of γδ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet's syndrome. Clin Exp Immunol 1990, 82:326-332. 1535141, 2122934.
14. Bank I, Duvdevani M, Livneh A. Expansion of γδ T-cells in Behcet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003, 141:33-40. 10.1067/mlc.2003.1, 12518166.
15. Freysdottir J, Lau S, Fortune F. γδ T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999, 118:451-457. 10.1046/j.1365-2249.1999.01069.x, 1905456, 10594567.
16. Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS. Vγ9Vδ2 T cells recovered from eyes of patients with Behcet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 2002, 130:46-54. 10.1016/S0165-5728(02)00208-4, 12225887.
17. Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Sano CD, Licata G. Vγ9/Vδ2 T lymphocytes in Italian patients with Behcet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease. Arthritis Res Ther 2003, 5:R262-R268. 10.1186/ar785, 193723, 12932289.
18. Kulaber A, Tugal-Tutkun I, Yentur SP, Akman-Demir G, Kaneko F, Gul A, Saruhan-Direskeneli G. Pro-inflammatory cellular immune response in Behcet's disease. Rheumat Int 2007, 27:1113-1118.
19. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080. International Study Group for Behçet's Disease.
20. Angelini DF, Zambello R, Galandrini R, Diamantini A, Placido R, Micucci F, Poccia F, Semenzato G, Borsellino G, Santoni A, Battistini L. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease. J Leukoc Biol 2011, 89:75-84. 10.1189/jlb.0710413, 20952657.
21. Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of V{γ9Vδ2 T cells by NKG2D. J Immunol 2005, 175:2144-2151.
22. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003, 3:781-790. 10.1038/nri1199, 14523385.
23. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000, 18:593-620. 10.1146/annurev.immunol.18.1.593, 10837070.
24. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001, 2:123-128. 10.1038/84219, 11175804.
25. Cipriani B, Borsellino G, Poccia F, Placido R, Tramonti D, Bach S, Battistini L, Brosnan CF. Activation of C-C beta chemokines in human peripheral blood γδ T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood 2000, 95:39-47.
26. Dagna L, Iellem A, Biswas P, Resta D, Tantardini F, Fortis C, Sabbadini MG, D'Ambrosio D, Manfredi AA, Ferrarini M. Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 γδ T lymphocytes. Eur J Immunol 2002, 32:2934-2943. 10.1002/1521-4141(2002010)32:10<2934::AID-IMMU2934>3.0.CO;2-6, 12355447.
27. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood γδ+ T cells and natural killer cells in Behcet's disease. J Rheumatol 1992, 19:588-592.
28. Ergun T, Eksioglu-Demiralp E, Direskeneli H, Mumcu G, Gurbuz O. TCR γδ(+) T-cell response to streptococcal antigens in patients with psoriasis. Arch Dermatol Res 2005, 296:536-538. 10.1007/s00403-005-0549-9, 15815916.
29. Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L, Aker F, Akoglu T. HSP 60 expression in mucocutaneous lesions of Behcet's disease. J Am Acad Dermatol 2001, 45:904-909. 10.1067/mjd.2001.117728, 11712037.
30. Freysdottir J, Hussain L, Farmer I, Lau SH, Fortune F. Diversity of γδ T cells in patients with Behcet's disease is indicative of polyclonal activation. Oral Dis 2006, 12:271-277. 10.1111/j.1601-0825.2005.01185.x, 16700735.
31. Yasuoka H, Yamaguchi Y, Mizuki N, Nishida T, Kawakami Y, Kuwana M. Preferential activation of circulating CD8+ and γδ T cells in patients with active Behcet's disease and HLA-B51. Clin Exp Rheumatol 2008, 26:S59-63.
32. Lamour A, Smith MD, Lydyard PM, Youinou PY. The majority of FcγRIII-positive γδ T cells do not express HLA-DR in patients with primary Sjogren's syndrome. Immunol Lett 1995, 45:153-155. 10.1016/0165-2478(94)00252-M, 7558166.
33. Chen Z, Freedman MS. Correlation of specialized CD16(+)γδ T cells with disease course and severity in multiple sclerosis. J Neuroimmunol 2008, 194:147-152. 10.1016/j.jneuroim.2007.11.010, 18155780.
34. Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, Kabelitz D. Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes: strong expression of CCR5 Is a selective feature of Vδ2/Vγ9 γδ T Cells. J Immunol 2002, 168:4920-4929.
35. Brandes M, Willimann K, Lang AB, Nam K-H, Jin C, Brenner MB, Morita CT, Moser B. Flexible migration program regulates γδ T-cell involvement in humoral immunity. Blood 2003, 102:3693-3701. 10.1182/blood-2003-04-1016, 12881309.
36. Li L, Wu C-Y. CD4+CD25+ Treg cells inhibit human memory γδ T cells to produce IFN-γ in response to M tuberculosis antigen ESAT-6. Blood 2008, 111:5629-5636. 10.1182/blood-2008-02-139899, 18388182.
37. Tanaka Y, Morita C, Nieves E, Brenner M, Bloom B. Natural and synthetic non peptide antigens recognized by human γδ T cells. Nature 1995, 375:155-158. 10.1038/375155a0, 7753173.
38. Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, Kou Z, Wang Q, Jiang L, Estep J, Hunt R, Clagett M, Sehgal PK, Li Y, Zeng X, Morita CT, Brenner MB, Letvin NL, Chen ZW. Adaptive immune response of Vγ2Vδ 2+ T cells during mycobacterial infections. Science 2002, 295:2255-2258. 10.1126/science.1068819, 2872146, 11910108.
39. Carvalho AC, Matteelli A, Airò P, Tedoldi S, Casalini C, Imberti L, Cadeo GP, Beltrame A, Carosi G. γδ T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection. Thorax 2002, 57:357-360. 10.1136/thorax.57.4.357, 1746296, 11923557.
40. Rojas RE, Chervenak KA, Thomas J, Morrow J, Nshuti L, Zalwango S, Mugerwa RD, Thiel BA, Whalen CC, Boom WH. Vδ2+γδ T cell function in Mycobacterium tuberculosis+ and HIV-1+positive patients in the United States and Uganda: application of a whole-blood assay. J Infect Dis 2005, 192:1806-1814. 10.1086/497146, 2869092, 16235181.
41. Gioia C, Agrati C, Casetti R, Cairo C, Borsellino G, Battistini L, Mancino G, Goletti D, Colizzi V, Pucillo LP, Poccia F. Lack of CD27-CD45RA-Vγ9Vδ2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol 2002, 168:1484-1489.
42. Boullier S, Poquet Y, Halary F, Bonneville M, Fournie JJ, Gougeon ML. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vγ9Vδ2 T cells but not on CD94- thymic or mature gammadelta T cell clones. Eur J Immunol 1998, 28:3399-3410. 10.1002/(SICI)1521-4141(199811)28:11<3399::AID-IMMU3399>3.0.CO;2-W, 9842883.
43. Riganti C, Massaia M, Davey MS, Eberl M. Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?. Eur J Immunol 42:1668-1676.
44. Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L, Lopez-Botet M, Fournie J, Gougeon M. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes. J Immunol 1997, 159:6009-6017.
45. Agrati C, Cimini E, Sacchi A, Bordoni V, Gioia C, Casetti R, Turchi F, Tripodi M, Martini F. Activated Vγ9Vδ2 T cells trigger granulocyte functions via MCP-2 release. J Immunol 2009, 182:522-529.
46. Accardo-Palumbo A, Ferrante A, Cadelo M, Ciccia F, Parrinello G, Lipari L, Giardina AR, Riili M, Giardina E, Dieli F, Triolo G. The level of soluble Granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behcet's disease. Clin Exp Rheumatol 2004, 22(4 Suppl 34):S45-49.